Immunomedics, Inc.
(NASDAQ : IMMU)

( )
IMMU PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.48%171.281.3%$490.30m
BIIBBiogen Inc.
-0.90%227.061.3%$435.96m
CELGCelgene Corporation
-0.41%95.241.3%$435.38m
GILDGilead Sciences, Inc.
-0.42%66.890.9%$421.14m
ILMNIllumina, Inc.
1.13%312.453.5%$304.49m
REGNRegeneron Pharmaceuticals, Inc.
-0.86%312.562.6%$284.79m
AAgilent Technologies, Inc.
0.99%68.371.6%$218.10m
VRTXVertex Pharmaceuticals Incorporated
-0.72%171.771.9%$178.12m
EXASExact Sciences Corporation
3.06%96.8825.3%$165.46m
ALXNAlexion Pharmaceuticals, Inc.
1.45%127.152.0%$148.25m
BMRNBioMarin Pharmaceutical Inc.
2.42%89.074.3%$119.32m
INCYIncyte Corporation
1.55%81.752.5%$110.60m
SRPTSarepta Therapeutics, Inc.
2.19%120.8414.7%$106.75m
ALNYAlnylam Pharmaceuticals, Inc
1.50%68.939.2%$99.72m
IONSIonis Pharmaceuticals, Inc.
-3.60%64.728.2%$96.34m

Company Profile

Immunomedics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. It operates through the United States, and Europe geographical segments. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.